Life Science Venture Transactions

Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. Adcentrx Therapeutics was founded in 2021 and is based in San Diego, California.

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

Sanguine BioSciences engages in-home specimen collection and a leader in direct-to-patient recruitment and digital health innovation. Sanguine BioSciences bridging the gap between patients and researchers to accelerate discovery and development. Sanguine BioSciences is based in Woburn, Massachusetts.

The BroadOak Fund
Investor
Growth Capital Firm
Bethesda, Maryland
www.broadoak.com

Alternative Bio is a biotechnology company developing novel therapeutics targeting a previously untapped class of post-translational modifying enzymes. Alternative Bio is based in Singapore.

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

Enhanc3D Genomics is a functional genomics company, unlocking the full potential of the human 3D genome to transform therapeutic development. Enhanc3D Genomics is based in Cambridge, United Kingdom.

BGF
Investor
Growth Capital Firm
London, United Kingdom
www.bgf.co.uk

Elucidata is a life sciences MLOps company for the future that transforms biological discovery by integrating different forms of biomedical data. Elucidata was founded in 2015 and is based in San Francisco, California.

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

Capstan Therapeutics is developing a targeted delivery platform and therapeutics to reprogram immune cells in vivo for a broad range of disease categories. Capstan was founded in 2021 and is based in San Diego, California.

Polaris Partners
Investor
Growth Capital Firm
Boston, Massachusetts
www.polarispartners.com

Tessa Therapeutics is a clinical-stage biotechnology company developing a portfolio of novel next-generation cell therapies for cancer. Tessa Therapeutics is based in Singapore.

Polaris Partners
Investor
Growth Capital Firm
Boston, Massachusetts
www.polarispartners.com

Mineralys is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. Its initial product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that the company is initially developing for the treatment of patients with uncontrolled hypertension. Mineralys was founded in 2019 and is based in Radnor, Pennsylvania.

Adams Street Partners
Investor
Asset Manager
Chicago, Illinois
www.adamsstreetpartners.com

Andera Partners
Investor
Private Equity Firm
Paris, France
www.anderapartners.com

HBM Partners
Investor
Private Equity Firm
Zug, Switzerland
www.hbmpartners.com

ImmunOs Therapeutics is a preclinical stage biotech company which develops a proprietary target discovery platform allowing to discover novel molecules inspired by HLA molecules and physiological immunosuppressive molecules. ImmunOs Therapeutics was founded in 2014 and is based in Schlieren, Switzerland.

GIMV
Investor
Private Equity Firm
Antwerp, Belgium
www.gimv.com

Vernal Biosciences provides mRNA and LNP-mRNA manufacturing services to democratize the use of mRNA for all use cases ranging from drug discovery to clinical development across all use cases such as gene editing and regulation, cellular programming, vaccines, mRNA replacement, oncology, autoimmune, and protein degradation. Vernal Biosciences is based in Colchester, Vermont.

Ampersand Capital Partners
Investor
Growth Capital Firm
Wellesley, Massachusetts
www.ampersandcapital.com

Ultima Genomics focuses on developing next-generation genome sequencing technology for the high-volume research and clinical markets. Ultima Genomics was founded in 2016 and is based in Fremont, California.

General Atlantic
Investor
Growth Capital Firm
New York, New York
www.generalatlantic.com

Invetx has built an integrated, best-in-class discovery, development, and manufacturing platform to create fully species-specific, optimized, and half-life extended product candidates. Invetx was founded in 2018 and is based in Boston, Massachusetts.

Eight Roads
Investor
Private Equity Firm
London, United Kingdom
www.eightroads.com

Tubulis develops next-generation antibody–drug conjugates by combining novel protein-linking technologies with disease-tailored payloads. The company creates highly stable ADCs designed to improve therapeutic precision and safety. Tubulis was founded in 2018 and is based in Planegg-Martinsried, Germany.

Andera Partners
Investor
Private Equity Firm
Paris, France
www.anderapartners.com

CytoTronics enables optics-free imaging for drug discovery through its complementary metal-oxide-semiconductor (CMOS) electronics platform. Building upon a suite of innovations licensed from Harvard University, CytoTronics’s technology measures and manipulates live cells to produce real-time, high resolution electrical and electrochemical cell-based assays. CytoTronics is based in Boston, Massachusetts.

Anzu Partners
Investor
Growth Capital Firm
Billerica, Massachusetts
www.anzupartners.com

Satellite Bio is developing satellite livers to bridge or replace liver transplantations. Satellite Bio was founded in 2019 and is based in Cambridge, Massachusetts.

Polaris Partners
Investor
Growth Capital Firm
Boston, Massachusetts
www.polarispartners.com

Aculys Pharma is a biopharmaceutical company focused on the development and commercialization of innovations in the fields of neurology and psychiatry. Aculys Pharma was founded in 2021 and is based in Minato-ku, Japan.

HBM Partners
Investor
Private Equity Firm
Zug, Switzerland
www.hbmpartners.com